HC Wainwright & Co. Reiterates Verona Pharma Plc – ADR (VRNA) Buy Recommendation

Fintel reports that on June 2, 2023, HC Wainwright & Co. reiterated coverage of Verona Pharma Plc – ADR (NASDAQ:VRNA) with a Buy recommendation.

admin